Summary

新加坡大选:前进党公布了另外六名候选人,且缩减了参与竞选的选区候选人名单

Jun 23, 2020 | 🚀 Fathership
新加坡 - 目前,新加坡前进党(PSP)准备在即将到来的大选中,竞争9个选区的议员席位,该党将派出24名(而不是最初宣布的44名)候选人参与选举。

前进党早些时候已将候选人名单削减至29个,称在与其他反对党讨论后将放弃一些席位,以避免三方角力。

周二,80岁的前进党秘书长陈清木在一次虚拟会议上透露,前进党打算竞争两个拥有五个席位的集选区,西海岸和丹戎巴葛,拥有四个席位的蔡厝港集选区,以及五个单席的集选区——康加北,先驱和新成立的玛丽蒙单,宏茂桥和哥本峇鲁集选区。 虽然这位前人民行动党议员和2011年总统大选候选人没有提到拥有五个席位的义顺选区,但他和几名前进党党员周日出现在忠邦与当地居民见面,他后来说该党正在考虑争夺该选区。

陈清木医生周二表示:“我们是根据能否获胜来选择要参选的选区,有些地方我很熟悉。比如,我在西部当过医生,在西部当过国会议员,所以我们专注于西部的选区。”

星期二,陈清木医生又公布了六名参选的候选人,其中包括五名首次参选的前进党候选人。

上周四,前进党首次公布了六名候选人名单,并于周末在几个选区进行了巡回演讲。

陈清木医生说:“我的政党不是一个人的政党,也不只是一个选区的政党……前进党将支持每一位党员。所以无论我们走到哪里,我们都是一个团队。”

65岁的洪永元医生是一位知名的精神科医生,曾作为新加坡民主党候选人参加2011年大选,并在2015年担任国人为先党主席。

陈清木医生并没有说明这些候选人在即将到来的大选中会参与哪一个选区的竞选,但Abas先生是陈清木医生在西海岸集选区的五人团队中最有希望获得最后席位的两名候选人之一,并且他也在该选区的传单中亮过相。

援引20岁当选的苏格兰民族党(Scottish National Party)议员梅莉•布莱克(Mhairi Black)和22岁当选内阁部长的阿联酋政界人士沙玛•阿尔•马兹瑞(Shamma Al Mazrui)的话,崔宣明表示:“世界各地的年轻人已经证明,他们同样可以在政坛中发挥重要作用。”

S'pore firm develops first Omicron-specific testing kit

Dec 06, 2021 | 🚀 Fathership
Home-grown biotechnology firm BioAcumen Global has launched Singapore's first Omicron-specific Covid-19 polymerase chain reaction (PCR) kit.

This means that a person taking the test will receive one of three results: Covid-19 positive and Omicron positive; Covid-19 positive and Omicron negative; or Covid-19 and Omicron negative.

Currently, PCR kits here that are capable of detecting Omicron require an additional gene sequencing step to confirm the specific variant. This takes an additional day.

Some PCR kits, such as those currently in use by medical technology firm Acumen Diagnostics and biotech firm MiRXES, are able to detect both the Delta and the Omicron strains, but to confirm if a positive case has been infected by Omicron, gene sequencing is necessary.

Mr Jimmy Toh, director of BioAcumen Global, said: "We are looking at ways to cut down the steps and time needed to run this test. This is crucial, especially at the borders where accurate tests need to be done on-site. There is no time to wait on sequencing results to know if a positive sample is infected with Omicron."

Mass production of the kit has begun, and the BioAcumen Global team hopes this kit will provide much needed help locally and in the region for the surveillance and control of this new variant, Mr Toh said.